alexa Policy Implications for Global Pervasive Nanotechnology Innovation | OMICS International
ISSN : 2153-2435
Pharmaceutica Analytica Acta
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Policy Implications for Global Pervasive Nanotechnology Innovation

Farid Menaa*

Department of Pharmaceutical Sciences and Nano-Medicine Fluorotronics,Inc. San Diego,California,USA

*Corresponding Author:
Farid Menaa, Director
Department of Pharmaceutical Sciences and Nano-Medicine Fluorotronics
Inc. San Diego, California, USA
Tel: (+1) 858-274-2728
E-mail: [email protected]

Received date: December 26, 2013; Accepted date: December 28, 2013; Published date: December 31, 2013

Citation: Menaa F (2013) Policy Implications for Global Pervasive Nanotechnology Innovation. Pharm Anal Acta. 5:e162. doi: 10.4172/2153-2435.1000e162

Copyright: © 2013 Menaa F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Pharmaceutica Analytica Acta

Nanotechnology is a fast growing branch of engineering that usually deals with dimensions and tolerances of less than 100 nanometers. Nanotechnology is an emerging and disruptive technology at the crossroads of several scientific fields, ranging from medicine (e.g. cancer nanotheranostics) to electronics (e.g. biosensors) [1-3]. Due to its potential in fast innovation and its socio-politico-economic impacts worldwide, it creates new opportunities and challenges that address global issues. Nanotechnology is promising “more for less” to several long-standing environmental and human concerns. Nevertheless, in some segments (e.g. medicine, food and cosmetics), nanosafety and “nano-ethical” concerns still require to be better addressed [4]. Indeed, according to one of my preliminary randomized surveys involving worldwide participants (n=100) aged from 15 to 80 years, 45% felt skeptical about nanotechnology, 35% felt good/enthusiastic and 20% did not know it, although the reality is that we use nanotechnologies in our everyday life (Figure 1).


Figure 1: Data from preliminary international survey about the perception of nanotechnology. The randomized study, realized from January to December 2013, involved worldwide participants (n=100) aged from 15 to 80 years.

Many countries have developed nanotechnology programs since the US National Nanotechnology Initiative was announced in 2000 [5-8]. According to the World Economic Forum´s Annual Global Competitiveness Report 2011 [9], nanotechnology is attracting more public and private fundings than any other area of technology worldwide, estimated in US $ multi-billion. Regulation of nanotechnology by the establishment of internationally-agreed policies is a must to objectively deal with several topics of increasing governmental interest such as international trade of nanoproducts, intellectual property, and nanotechnological transfers. The issue of nanotechnology global governance (i.e. conciliation of diverging interests aka “coherent standardization agreement”) and its overall impacts (including risks) are at the crossroads [10]. Therefore, the intervention of the worldwide societies (i.e. developed and developing countries), worldwide policymakers (e.g. OECD, UNESCO, ISO, IBSA, WPMN, WPN, FDA), stakeholders (e.g. private initiatives such as ICON, IRGC, public funding institutions such as WHO and UNEP) and the financial and insurance sectors, is required to undertake fairest decisions and define an appropriate model for nanotechnology regulation, considering the model of “responsible/pervasive innovation” [10]. Further, a framework for global legal authority and transjudicial cooperation is needed [11]. Besides, nanoscience and nanotechnology indicators shall give insights [12]. For instance, indicated stage of maturity of a given nanotechnology can be used to depict scenarios for future evolution and for decision makers to design an appropriate strategy [12]. Also, key issues to reach a more objective dialogue include potential or confirmed risks, data transparency and accessibility (e.g. via openaccess online publications), society´s opinion. Eventually, a balanced approach of risks and benefits of research and development (R&D), commercialization and trade of nanoproducts, arising among public and private decision-makers, is important in an economy perspective.

Up-to-date, several countries including the BRICS (Brazil, Russia, India, China, South Africa), all the European Union Member States, most of the OECD (e.g. Japan, Taiwan, Israel), and also Korea, Argentina, Malaysia, Turkey, Morocco, Saudi Arabia, have adopted public policies supportive of research and innovation in the field of nanoscience and nanotechnology (i.e. precautionary approach with regards to health, environment, legal and ethical issues) [10].

Nanotechnology and below scales technologies (e.g. picotechnology) are quite promising for R&D applications worldwide, then impact our societies by bringing new solutions but shall be quite well regulated to avoid that these small worlds generate big issues.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

  • 7th International Conference on Phamaceutical Auditing
    June 08-09, 2018 Baltimore, USA
  • 4th International Conference on Drug Discovery, Designing and Development
    June 27-28, 2018 Vancouver, Canada
  • 18th World Pharma Congress
    October 18-19, 2018 Warsaw, Poland

Article Usage

  • Total views: 11729
  • [From(publication date):
    January-2014 - Apr 22, 2018]
  • Breakdown by view type
  • HTML page views : 7956
  • PDF downloads : 3773

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engineeringjourna[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version